Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

1249 Results Found

FDA issues import alert, additional recommendations against using plastic syringes made in China 

The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to recommendations against using any other Chinese-manufactured plastic syringes.

New AHA resource offers strategies to mitigate violence and promote a culture of safety 

A new issue brief from AHA’s Hospitals Against Violence initiative offers proven strategies and action steps to help hospitals and health systems’ violence mitigation efforts fit into the organization’s culture of safety strategy and lead to better patient outcomes.

AHA urges congressional support of health care programs in FY 2025 appropriations

AHA urged leaders of the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, and Education to give favorable funding consideration in fiscal year 2025 to health care programs shown to improve access to quality health care for patients and communities. 

DOJ announces task force on health care monopolies and collusion

The Department of Justice May 9 announced the formation of a task force focusing on competition concerns in health care.

FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance

The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devic

CMS releases report on Medicare Advantage coverage disparities based on race, ethnicity and sex 

A report from the Centers for Medicare & Medicaid Services examining disparities in care based on race, ethnicity and sex shows that in 2023, clinical care disparities were most common for Native American and African-American enrollees.

HHS final rule strengthens protections against disability discrimination

The Department of Health and Human Services May 1 released a final rule bolstering discrimination protections for people with disabilities under Section 504 of the Rehabilitation Act.

FDA issues final rule applying medical device rules to laboratory developed tests 

The Food and Drug Administration April 29 issued a final rule that would phase out its general enforcement discretion approach for most laboratory developed tests over four years, citing concern that some of the tests may not provide accurate results or perform as well as FDA-approved in vitro diagnostic products.

AHA blog shares ways to prevent pediatric sepsis

Pediatric sepsis is "an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds," writes Chris DeRienzo, M.D., AHA’s senior vice president and chief physician executive, in a blog about his experiences treating the condition as a physician and the importance of prevention.

CDC investigating counterfeit, mishandled botulinum toxin injections

The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received botulinum toxin injections that were counterfeit or administered in non-healthcare settings or by unlicensed or untrained individuals.